Drug-drug interactions with sodium-glucose cotransporters type 2 (SGLT2) inhibitors, new oral glucose-lowering agents for the management of type 2 diabetes mellitus. [electronic resource]
- Clinical pharmacokinetics Apr 2014
- 295-304 p. digital
Publication Type: Journal Article; Review
1179-1926
10.1007/s40262-013-0128-8 doi
Diabetes Mellitus, Type 2--drug therapy Drug Interactions Humans Hypoglycemic Agents--adverse effects Sodium-Glucose Transporter 2 Sodium-Glucose Transporter 2 Inhibitors